Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Imaizumi, Kent  [Clear All Filters]
2023
Meng X, Yao D, Imaizumi K, Chen X, Kelley KW, Reis N, Thete MVijay, McKinney AArjun, Kulkarni S, Panagiotakos G, et al. Assembloid CRISPR screens reveal impact of disease genes in human neurodevelopment. Nature. 2023.
Watanabe H, Murakami R, Tsumagari K, Morimoto S, Hashimoto T, Imaizumi K, Sonn I, Yamada K, Saito Y, Murayama S, et al. Astrocytic APOE4 genotype-mediated negative impacts on synaptic architecture in human pluripotent stem cell model. Stem Cell Reports. 2023.
2022
Kitagawa T, Nagoshi N, Kamata Y, Kawai M, Ago K, Kajikawa K, Shibata R, Sato Y, Imaizumi K, Shindo T, et al. Modulation by DREADD reveals the therapeutic effect of human iPSC-derived neuronal activity on functional recovery after spinal cord injury. Stem Cell Reports. 2022;17(1):127-142.
Imaizumi K, Ideno H, Sato T, Morimoto S, Okano H. Pathogenic mutation of TDP-43 impairs RNA processing in a cell type-specific manner: implications for the pathogenesis of ALS/FTLD. eNeuro. 2022.
2021
Kawai M, Imaizumi K, Ishikawa M, Shibata S, Shinozaki M, Shibata T, Hashimoto S, Kitagawa T, Ago K, Kajikawa K, et al. Long-term selective stimulation of transplanted neural stem/progenitor cells for spinal cord injury improves locomotor function. Cell Rep. 2021;37(8):110019.
2019
Sho M, Ichiyanagi N, Imaizumi K, Ishikawa M, Morimoto S, Watanabe H, Okano H. A combinational treatment of carotenoids decreases Aβ secretion in human neurons via β-secretase inhibition. Neurosci Res. 2019.